Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

dDecember 31,December 31,(Unaudited; $ in millions)2012201120122011Product sales

$
,388.7$
,161.4$
4,385.2$
3,320.2Other revenue

25.410.960.947.0Net revenue

1,414.11,172.34,446.13,367.2Operating expenses:Cost of sales

809.3652.02,428.41,817.8Research and development

90.460.3255.6227.7Selling and marketing

129.142.5281.2156.0Segment contribution

$
385.3$
417.5$
,480.9$
,165.7Segment margin

27.2%35.6%33.3%34.6%Adjusted gross profit (1)

$
.4$
513.7$
2,067.1$
,551.2Adjusted gross margin

46.7%43.8%46.6%46.2%(1)Adjusted gross profit represents adjusted net revenue less adjusted cost of sales and excludes amortization of acquired intangibles. Pro forma adjustments for the respective periods include the following: Settlement of contingent asset acquired as part of a

business acquisition (other revenue)

$
-$
-$
-$
(7.4)Net revenue from payment received relating to

previously divested business

--(10.9)$
(2.4)Operational Excellence Initiative

8.91.213.69.4Acquisition accounting adjustments

46.7(7.8)46.72.2Actavis Pharma net revenue for the fourth quarter 2012 increased 21 percent to $1.4 billion primarily as a result of the inclusion of legacy Actavis as of November 1, 2012, and increased sales related to new products in key markets including generic versions of Lovenox®, Xopenex® and Adderall XR® in the U.S.  This partially offset lower U.S. sales of the generic versions of Lipitor® and Toprol XL®. Fourth quarter international net revenue was $524.7 million, up 245 percent from the fourth quarter 2011, primarily as a result of the inclusion of legacy Actavis results.  

Actavis Pharma R&D investment for the fourth quarter 2012 increased 50 percent to $90.4 milli
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 22, 2014  Cephasonics, a technology-innovation leader with a ... cQUB™-1 (cQuest Ultrasound Box™-1), the first product in a ... manufactured by Cephasonics for purchase by companies to rebrand ... will be showcasing the cQUB-1 for the first time ... Chongqing, China from October 23 ...
(Date:10/22/2014)... -- Quest Diagnostics (NYSE: DGX ), the world,s ... its Board of Directors has elected Jeffrey M. Leiden, ... 2014. Including Dr. Leiden, the Board has 11 members. ... CEO of Vertex Pharmaceuticals.   Dr. Leiden has more ... the pharmaceutical and biotechnology industries as well as clinical ...
(Date:10/22/2014)... 22, 2014 Antigen Discovery Inc. (ADi), a ... , announced the receipt of a National Institutes of ... from the National Institute of Dental and Craniofacial Research (NIDCR). ... a Pan-HIV Protein Microarray Chip, which will contain every ... and aid in the development of safe and effective ...
Breaking Medicine Technology:Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2
... 14, 2011 Cardinal Health plans to release fourth-quarter and ... 4, prior to the opening of trading on the New ... webcast and conference call for Aug. 4 at 8:30 a.m. ... corresponding slide presentation, go to the Investors page at cardinalhealth.com/investors ...
... July 14, 2011 Delcath Systems, Inc. (NASDAQ: ... its common stock pursuant to an underwriting agreement with Jefferies ... The Company expects to use the net proceeds from the ... not limited to, commercialization of our products, obtaining regulatory approvals, ...
Cached Medicine Technology:Cardinal Health to Release Fourth-quarter and Full-year Results for Fiscal Year 2011 on Aug. 4 2Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock 2Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock 3
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/22/2014)... By Dennis Thompson HealthDay ... freelance cameraman who was diagnosed with Ebola while working for ... system and can leave the special isolation unit at Nebraska Medical ... two weeks, the hospital said Tuesday. A blood test confirmed ... Ashoka Mukpo, 33, can head home to Providence, R.I., NBC ...
(Date:10/20/2014)... With a mere 19 days to November 4, ... fundraising stop at the  Law Offices of Dan ... debate last night with his opponent Gov. Rick Scott, ... seven minutes because Crist had an electric fan underneath ... one word: "weird." , Before touching on his well-known ...
(Date:10/20/2014)... The Advocator Group, LLC is proud ... for Suicide Prevention’s (AFSP) Out of the Darkness walk ... that hosts hundreds of community walks throughout the country ... to help understand and prevent suicide through not only ... , The Advocator Group shares this passion for ...
(Date:10/20/2014)... Women’s health specialist, Dr. Amber Murphy, ... of Columbus, Inc., A Division of MaternOhio Clinical Associates, ... than 100,000 patients annually. Dr. Murphy will provide a ... of a women’s life. She is accepting new patients ... and Dublin. , Dr. Murphy offers a wide variety ...
Breaking Medicine News(10 mins):Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3
... a dose of 20 mg per day can help people ... help prevent the weight gain that so often accompanies attempts ... was not shown to be effective. ,Smoking tobacco ... the endocannabinoid system, part of the hormonal control mechanism in ...
... chemical compound found in turmeric may help beat Alzheimer's, ... ,Researchers isolated the compound 'bisdemethoxycurcumin' found in ... that defend the body against infections and diseases. ... compound into patients and treat the incurable and fatal ...
... after President Bush unveiled a plan for coping with a ... capacity to detect a disease outbreak and track its progress ... it will not close the borders if a pandemic flu ... special assistant to the president for biodefense:The reality is that ...
... smoking, but are prepared to try and reduce the numbers ... studying healthcare literature, a team of Cochrane Researchers could find ... people reduce use. It is also unclear whether cutting down ... main effort in therapies aimed at smokers has been at ...
... the law so that anyone who dies is presumed to have ... specific opt-out, was urged Tuesday by Chief Medical Officer Liam ... donation that leaves around 7,000 people on the transplant waiting list ... of a crisis in this country," said Donaldson. "Every day at ...
... come into effect in several European countries, and Germany is set ... been a better time to kick the habit, but smokers should ... be much harder. Statistics show that only 1-2 percent of smokers ... least, smokers are vanishing fast, mainly because hardly anyone actually takes ...
Cached Medicine News:Health News:20 Mg Rimonabant Per Day may Help to Quit Smoking 2Health News:Americas Preparations For Flu Outbreak Still Incomplete 2Health News:Reducing Smoking - Mixed Messages and Latest Findings 2Health News:Group Therapy and Willpower can Help Smokers to Quit 2
Intact PTH EIA Bone and Mineral Metabolism 021-SDX016 Parathyroid Hormone...
EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia...
... Immunoscan MPO-ANCA Kit is an enzyme immunoassay ... in human serum of the subclass of ... to be used as an aid in ... family of autoantibodies associated with vasculitic disorders ...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
Medicine Products: